Hal Barron
CIK 1418677 · SVP - DEVELOPMENT & CMO · last filed 2026-06-08
Hal Barron is a SVP - DEVELOPMENT & CMO who has filed 22 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for QNT, was dated Jun 8, 2026. Across all open-market trades the lifetime net is +$17.4M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
22
$17.40M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QNT | Director | 255,833 | — | — | $15.00M | 1 | 2026-06-08 |
| Juno Therapeutics, Inc. (JUNO) Delisted | Director | 0 | — | — | $2.40M | 13 | 2018-03-07 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | Director | 3,492 | — | — | $0 | 7 | 2013-08-19 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | QNT | Mixed | +255,833 | $15.00M | EDGAR |
| 2018-03-07 | Juno Therapeutics, Inc. (JUNO) Delisted | Mixed | −103,780 | -$9.03M | EDGAR |
| 2018-01-09 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +336 | $0 | EDGAR |
| 2017-10-06 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +361 | $0 | EDGAR |
| 2017-07-07 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +516 | $0 | EDGAR |
| 2017-06-19 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-06 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +698 | $0 | EDGAR |
| 2017-01-09 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +768 | $0 | EDGAR |
| 2016-10-17 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +438 | $0 | EDGAR |
| 2016-07-05 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +328 | $0 | EDGAR |